Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The Genetic and Epigenetic Features of Bilateral Wilms Tumor Predisposition

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Homo sapiens

PROVIDER: GSE226480 | GEO | 2023/11/09

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

The Genetic and Epigenetic Features of Bilateral Wilms Tumor Predisposition [RNA-Seq]

Project description:This study comprehensively evaluated the landscape of genetic and epigenetic events that predispose to synchronous bilateral Wilms tumor (BWT). We performed whole exome or whole genome sequencing, total-strand RNA-seq, and DNA methylation analysis using germline and/or tumor samples from 68 patients with BWT from St. Jude Children’s Research Hospital and the Children’s Oncology Group.

2023-11-10 | GSE226478 | GEO

The Genetic and Epigenetic Features of Bilateral Wilms Tumor Predisposition [DNA methylation]

2023-11-10 | GSE226234 | GEO

Genetic and epigenetic features of bilateral Wilms tumor predisposition in patients from the Children's Oncology Group AREN18B5-Q.

Project description:Developing synchronous bilateral Wilms tumor suggests an underlying (epi)genetic predisposition. Here, we evaluate this predisposition in 68 patients using whole exome or genome sequencing (n = 85 tumors from 61 patients with matched germline blood DNA), RNA-seq (n = 99 tumors), and DNA methylation analysis (n = 61 peripheral blood, n = 29 non-diseased kidney, n = 99 tumors). We determine the predominant events for bilateral Wilms tumor predisposition: 1)pre-zygotic germline genetic variants readily detectable in blood DNA [WT1 (14.8%), NYNRIN (6.6%), TRIM28 (5%), and BRCA-related genes (5%)] or 2)post-zygotic epigenetic hypermethylation at 11p15.5 H19/ICR1 that may require analysis of multiple tissue types for diagnosis. Of 99 total tumor specimens, 16 (16.1%) have 11p15.5 normal retention of imprinting, 25 (25.2%) have 11p15.5 copy neutral loss of heterozygosity, and 58 (58.6%) have 11p15.5 H19/ICR1 epigenetic hypermethylation (loss of imprinting). Here, we ascertain the epigenetic and genetic modes of bilateral Wilms tumor predisposition.

| S-EPMC10728430 | biostudies-literature

The Genetic and Epigenetic Features of Bilateral Wilms Tumor Predisposition

Project description:The Genetic and Epigenetic Features of Bilateral Wilms Tumor Predisposition

| PRJNA940412 | ENA

The Genetic and Epigenetic Features of Bilateral Wilms Tumor Predisposition [RNA-Seq]

Project description:The Genetic and Epigenetic Features of Bilateral Wilms Tumor Predisposition [RNA-Seq]

| PRJNA940419 | ENA

The Genetic and Epigenetic Features of Bilateral Wilms Tumor Predisposition [DNA methylation]

Project description:The Genetic and Epigenetic Features of Bilateral Wilms Tumor Predisposition [DNA methylation]

| PRJNA939213 | ENA

Germline Variant in *Ctcf* Links Mental Retardation to Wilms Tumor Predisposition

Project description:This SuperSeries is composed of the SubSeries listed below.

2022-01-11 | GSE193235 | GEO

Stratification of Wilms tumor by genetic and epigenetic analysis.

Project description:Somatic defects at five loci, WT1, CTNNB1, WTX, TP53 and the imprinted 11p15 region, are implicated in Wilms tumor, the commonest childhood kidney cancer. In this study we analysed all five loci in 120 Wilms tumors. We identified epigenetic 11p15 abnormalities in 69% of tumors, 37% were H19 epimutations and 32% were paternal uniparental disomy (pUPD). We identified mutations of WTX in 32%, CTNNB1 in 15%, WT1 in 12% and TP53 in 5% of tumors. We identified several significant associations: between 11p15 and WTX (P=0.007), between WT1 and CTNNB1 (P less than 0.001), between WT1 and pUPD 11p15 (P=0.01), and a strong negative association between WT1 and H19 epimutation (P less than 0.001). We next used these data to stratify Wilms tumor into three molecular Groups, based on the status at 11p15 and WT1. Group 1 tumors (63%) were defined as 11p15-mutant and WT1-normal; a third also had WTX mutations. Group 2 tumors (13%) were WT1-mutant. They either had 11p15 pUPD or were 11p15-normal. Almost all had CTNNB1 mutations but none had H19 epimutation. Group 3 tumors (25%) were defined as 11p15-normal and WT1-normal and were typically normal at all five loci (P less than 0.001). We also identified a novel clinical association between H19 epimutation and bilateral disease (P less than 0.001). These data provide new insights into the pattern, order, interactions and clinical associations of molecular events in Wilms tumor.

| S-EPMC3359888 | biostudies-other

miRNA and Wilms' tumor

Project description:This SuperSeries is composed of the SubSeries listed below.

2012-03-31 | GSE28401 | GEO

Genetic, functional and molecular features of glucocorticoid receptor binding

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2013-04-01 | E-GEOD-45640 | biostudies-arrayexpress